HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 108 | 120 | 90.0% | |
| HF004 | 2020 | 138 | 148 | 93.2% | |
| HF006 | 2021 | 162 | 181 | 89.5% | |
| HF006 | 2022 | 213 | 217 | 98.2% | |
| HF006 | 2023 | 243 | 251 | 96.8% |
